Capecitabine rapidly disintegrating tablets

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 9/36 (2006.01) A61K 9/00 (2006.01) A61K 31/7068 (2006.01)

Patent

CA 2745279

There is provided a film coated pharmaceutical composition comprising 5'-deoxy- 5-fluoro-N-[(pentyloxy)-carbonyl]-cytidine (capecitabine) and at least one disintegrant selected from the group comprising of crospovidone (particle size < 15-400 µ), croscarmellose sodium, sodium starch glycolate, low- substituted hydroxypropylcellulose, Ludiflash ® or any combination of these, together with other pharmaceutically acceptable excipients to form a rapidly disintegrating tablet.

L'invention porte sur une composition pharmaceutique revêtue d'un film comprenant de la 5'-désoxy-5-fluoro-N-[(pentyloxy)-carbonyl]-cytidine (capécitabine) et au moins un agent de désintégration choisi dans le groupe constitué par la crospovidone (dimension de particule < 15-400 µ), le sodium de croscarmellose, le glycolate d'amidon sodique, l'hydroxypropylcellulose faiblement substituée, le Ludiflash® ou toute combinaison de ceux-ci, conjointement avec d'autres excipients pharmaceutiquement acceptables pour former un comprimé se désintégrant rapidement.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Capecitabine rapidly disintegrating tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Capecitabine rapidly disintegrating tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Capecitabine rapidly disintegrating tablets will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1685218

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.